Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) EBIT Margin (2020 - 2026)

Sotera Health has reported EBIT Margin over the past 6 years, most recently at 35.73% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 570.0% year-over-year to 35.73%; the TTM value through Dec 2025 reached 33.75%, up 671.0%, while the annual FY2025 figure was 33.75%, 671.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 35.73% at Sotera Health, down from 36.7% in the prior quarter.
  • Over five years, EBIT Margin peaked at 36.7% in Q3 2025 and troughed at 15.13% in Q1 2023.
  • A 5-year average of 27.6% and a median of 27.98% in 2024 define the central range for EBIT Margin.
  • Biggest five-year swings in EBIT Margin: tumbled -50157bps in 2021 and later skyrocketed 962bps in 2023.
  • Year by year, EBIT Margin stood at 27.53% in 2021, then fell by -13bps to 23.92% in 2022, then surged by 40bps to 33.53% in 2023, then fell by -10bps to 30.03% in 2024, then rose by 19bps to 35.73% in 2025.
  • Business Quant data shows EBIT Margin for SHC at 35.73% in Q4 2025, 36.7% in Q3 2025, and 33.2% in Q2 2025.